Organicell Reports the Expansion of its Trial for Zofin to Treat COVID-19 Patients in India
Shots:
- The company reported the positive results of the initial trial for Zofin in the first 10 COVID-19 patients treated with Zofin in India. The trial is being conducted with CWI India and showed all patients have recovered from their symptoms and were discharged from the hospital
- Based on the positive results- the trial will be expanded to additional 65 patients with the mod. to sev. COVID-19 and is expected to be completed by Jun’2021
- If the expanded trial will show similar results as an initial trial- Organicell and CWI India plan to file EUA with the ICMR to use Zofin in India as a treatment for COVID-19
Ref: Business Wire | Image: Business Wire
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com